Recruiting × Esophageal Neoplasms × Gastrointestinal × Clear all National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
REACH
Phase NA Recruiting
257 enrolled
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Phase 1 Recruiting
42 enrolled
The Vanguard Study: Testing a New Way to Screen for Cancer
Phase NA Recruiting
24,000 enrolled
MK-3475-06D
Phase 1/2 Recruiting
210 enrolled
MK-3475-06C
Phase 1/2 Recruiting
160 enrolled
FAPI-GO
Phase 3 Recruiting
200 enrolled
ELEPHAS-04
Recruiting
324 enrolled
GENCONCOR-2
Recruiting
30 enrolled
HEARTS Trial for Thoracic Cancers
Phase 2 Recruiting
60 enrolled
PEGASUS
Phase 2 Recruiting
30 enrolled
Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
Recruiting
1,500 enrolled
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
4,000 enrolled
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Phase 4 Recruiting
22 enrolled
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Phase 2 Recruiting
40 enrolled
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Recruiting
5,000 enrolled
MOMENTUM
Recruiting
8,000 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer
Phase 1/2 Recruiting
105 enrolled
MK-3475-06B
Phase 1/2 Recruiting
230 enrolled
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 Recruiting
134 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 Recruiting
60 enrolled
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Phase NA Recruiting
600 enrolled
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
22 enrolled
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 Recruiting
200 enrolled
Endeavor-1
Phase NA Recruiting
50 enrolled
DP-04
Recruiting
100 enrolled
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Phase 3 Recruiting
2,130 enrolled
DG-03
Phase 2 Recruiting
450 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Recruiting
80 enrolled
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Recruiting
60 enrolled
MAGECmultiDiCE
Phase NA Recruiting
2,200 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Recruiting
1,310 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Phase NA Recruiting
200 enrolled
MAGEC
Phase NA Recruiting
1,000 enrolled
EXCEED
Phase 1 Recruiting
490 enrolled
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Phase NA Recruiting
20 enrolled
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 Recruiting
452 enrolled
VISTA
Phase 1 Recruiting
45 enrolled
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 Recruiting
150 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
OPTIMUS
Phase NA Recruiting
50 enrolled
POISE
Phase 3 Recruiting
20 enrolled
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 Recruiting
470 enrolled
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2 Recruiting
49 enrolled